Frank Rimerman Advisors LLC Has $9.42 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Frank Rimerman Advisors LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,104 shares of the healthcare conglomerate’s stock after purchasing an additional 1,355 shares during the period. UnitedHealth Group makes up about 0.7% of Frank Rimerman Advisors LLC’s portfolio, making the stock its 22nd biggest holding. Frank Rimerman Advisors LLC’s holdings in UnitedHealth Group were worth $9,416,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Smith Salley Wealth Management grew its stake in UnitedHealth Group by 32.4% during the third quarter. Smith Salley Wealth Management now owns 3,643 shares of the healthcare conglomerate’s stock worth $2,130,000 after buying an additional 892 shares in the last quarter. DekaBank Deutsche Girozentrale lifted its stake in UnitedHealth Group by 0.6% during the third quarter. DekaBank Deutsche Girozentrale now owns 936,422 shares of the healthcare conglomerate’s stock worth $543,770,000 after purchasing an additional 5,228 shares during the last quarter. Modera Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 0.7% during the 3rd quarter. Modera Wealth Management LLC now owns 36,537 shares of the healthcare conglomerate’s stock worth $21,363,000 after buying an additional 257 shares in the last quarter. GHP Investment Advisors Inc. boosted its stake in UnitedHealth Group by 0.7% in the third quarter. GHP Investment Advisors Inc. now owns 17,046 shares of the healthcare conglomerate’s stock valued at $9,966,000 after buying an additional 114 shares in the last quarter. Finally, Covenant Partners LLC boosted its stake in shares of UnitedHealth Group by 1.2% in the 3rd quarter. Covenant Partners LLC now owns 2,205 shares of the healthcare conglomerate’s stock valued at $1,289,000 after purchasing an additional 27 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent research reports. Royal Bank of Canada cut their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Bank of America reduced their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Barclays cut their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Wells Fargo & Company raised their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Trading Up 0.7 %

Shares of UNH opened at $564.56 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The firm has a market cap of $521.33 billion, a P/E ratio of 36.78, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63. The business has a 50-day moving average of $583.52 and a 200 day moving average of $537.96.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the company earned $6.56 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.